PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha, Aseer 62529, Saudi Arabia.\', \'School of Chemistry and Physics, Faculty of Science, Queensland University of Technology, Brisbane, Queensland, Australia.\', \'Queensland University of Technology, Centre for Biomedical Technology, Brisbane, Queensland, Australia.\', \'Pharmacy Discipline, School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.\', \'Queensland University of Technology, Centre for Biomedical Technology, Brisbane, Queensland, Australia; Australia-China Centre for Tissue Engineering and Regenerative Medicine, Queensland University of Technology, Brisbane, Queensland, Australia.\', \'Central Analytical Research Facility, Institution for Future Environment, Queensland University of Technology, Brisbane, Queensland, Australia.\', \'Pharmacy Discipline, School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia; Centre for Immunology and Infection Control (CIIC), Queensland University of Technology (QUT), Brisbane, Queensland, Australia. Electronic address: nazrul.islam@qut.edu.au.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0378-5173(21)00928-510.1016/j.ijpharm.2021.121122
?:hasPublicationType
?:journal
  • International journal of pharmaceutics
is ?:pmid of
?:pmid
?:pmid
  • 34560207
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.172
?:rankingScore_hIndex
  • 179
is ?:relation_isRelatedTo_publication of
?:title
  • Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34560207>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34560207>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all